Comparison

Emricasan European Partner

Item no. TMO-T6826-50mg
Manufacturer TargetMol
CASRN 254750-02-2
Amount 50 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations Barreyro FJ, et al. Liver Int. 2015, 35(3):953-66.
Smiles C[C@H](NC(=O)C(=O)Nc1ccccc1C(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)COc1c(F)c(F)cc(F)c1F
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias PF 03491390,IDN-6556
Shipping Condition Cool pack
Available
Manufacturer - Targets
Caspase|||Influenza Virus
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
569.5
Description
Emricasan (IDN-6556) is a pan-caspase inhibitor with irreversible properties. Emricasan has anti-inflammatory and anti-apoptotic activity and can be used in the treatment of infections and liver failure, etc. Emricasan also inhibits Zika virus infections.
Pathways
Apoptosis|||Microbiology/Virology|||Proteases/Proteasome

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close